| |
| |
|
| Insider
Information: |
Winningham Rick E |
| Relationship: |
|
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
2,686,408 |
|
|
Indirect Shares
|
96,467 |
|
|
| Direct
Value |
$32,096,465 |
|
|
|
Indirect Value
|
$926,083 |
|
|
| Total
Shares |
2,782,875 |
|
|
| Total
Value |
$33,022,548 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -15.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Innoviva Inc |
INVA |
Director |
2014-08-15 |
825,391 |
2008-01-29 |
0 |
Premium* |
|
|
Jazz Pharmaceuticals Inc |
JAZZ |
Director |
2023-08-14 |
10,444 |
2012-01-11 |
0 |
Premium* |
|
|
Theravance Biopharma, Inc. |
TBPH |
|
2024-04-02 |
1,850,573 |
2024-04-02 |
96,467 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
130 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
• • – |
2018-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
28,000 |
894,377 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
• • – |
2018-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
105,000 |
987,237 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2018-08-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,495 |
12,589 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
• • – |
2019-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
317,000 |
1,112,939 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2019-08-08 |
4 |
A |
$0.00 |
$0 |
D/D |
1,920 |
5,150 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
• • – |
2020-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
338,000 |
1,412,455 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2020-08-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,705 |
7,129 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
• • – |
2021-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
170,000 |
1,445,169 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2021-07-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,246 |
8,444 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
CHIEF EXECUTIVE OFFICER |
• • – |
2022-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
170,000 |
1,449,300 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2022-08-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,561 |
9,699 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
CHIEF EXECUTIVE OFFICER |
• • – |
2022-12-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
9,000 |
1,400,797 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
CHIEF EXECUTIVE OFFICER |
• • – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
330,000 |
1,643,377 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2023-08-11 |
4 |
A |
$0.00 |
$0 |
D/D |
3,075 |
11,685 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-03-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,900 |
1,550,573 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-03-15 |
4 |
GA |
$0.00 |
$0 |
I/I |
3,900 |
3,900 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-04-02 |
4 |
A |
$0.00 |
$0 |
D/D |
300,000 |
1,850,573 |
0 |
- |
|
| INVA |
Innoviva Inc |
Chief Executive Officer |
• • – |
2012-05-04 |
4 |
OE |
$3.10 |
$400,070 |
D/D |
63,225 |
532,527 |
0 |
- |
|
| INVA |
Innoviva Inc |
Chief Executive Officer |
• • – |
2012-08-03 |
4 |
OE |
$3.10 |
$449,999 |
D/D |
145,161 |
667,007 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2012-01-11 |
4 |
OE |
$8.23 |
$842,950 |
D/D |
55,000 |
46,656 |
0 |
- |
|
| INVA |
Innoviva Inc |
Chief Executive Officer |
• • – |
2011-02-22 |
4 |
OE |
$8.53 |
$2,200,644 |
D/D |
258,140 |
680,173 |
0 |
- |
|
| INVA |
Innoviva Inc |
Chief Executive Officer |
• • – |
2011-02-23 |
4 |
OE |
$8.53 |
$1,214,813 |
D/D |
142,500 |
653,873 |
0 |
- |
|
| INVA |
Innoviva Inc |
Chief Executive Officer |
• • – |
2011-02-24 |
4 |
OE |
$8.53 |
$1,158,974 |
D/D |
135,950 |
692,223 |
0 |
- |
|
| INVA |
Innoviva Inc |
Chief Executive Officer |
• • – |
2011-02-25 |
4 |
OE |
$8.53 |
$1,158,121 |
D/D |
135,850 |
734,973 |
0 |
- |
|
| INVA |
Innoviva Inc |
Chief Executive Officer |
• • – |
2011-02-28 |
4 |
OE |
$8.53 |
$867,436 |
D/D |
101,752 |
744,525 |
0 |
- |
|
130 Records found
|
|
Page 2 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
